These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31100549)

  • 1. Metadynamics simulations of ligand binding to GPCRs.
    Ibrahim P; Clark T
    Curr Opin Struct Biol; 2019 Apr; 55():129-137. PubMed ID: 31100549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Metadynamics-Based Protocol for the Determination of GPCR-Ligand Binding Modes.
    Söldner CA; Horn AHC; Sticht H
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCRs: What Can We Learn from Molecular Dynamics Simulations?
    Velgy N; Hedger G; Biggin PC
    Methods Mol Biol; 2018; 1705():133-158. PubMed ID: 29188561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended Metadynamics Protocol for Binding/Unbinding Free Energies of Peptide Ligands to Class A G-Protein-Coupled Receptors.
    Calderón JC; Plut E; Keller M; Cabrele C; Reiser O; Gervasio FL; Clark T
    J Chem Inf Model; 2024 Jan; 64(1):205-218. PubMed ID: 38150388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Efficient Metadynamics-Based Protocol To Model the Binding Affinity and the Transition State Ensemble of G-Protein-Coupled Receptor Ligands.
    Saleh N; Ibrahim P; Saladino G; Gervasio FL; Clark T
    J Chem Inf Model; 2017 May; 57(5):1210-1217. PubMed ID: 28453271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating Small-Molecule Ligand Binding to G Protein-Coupled Receptors with Biased or Unbiased Molecular Dynamics Simulations.
    Marino KA; Filizola M
    Methods Mol Biol; 2018; 1705():351-364. PubMed ID: 29188572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General Metadynamics Protocol To Simulate Activation/Deactivation of Class A GPCRs: Proof of Principle for the Serotonin Receptor.
    Calderón JC; Ibrahim P; Gobbo D; Gervasio FL; Clark T
    J Chem Inf Model; 2023 May; 63(10):3105-3117. PubMed ID: 37161278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of multiscale simulations on GPCRs.
    Durdagi S; Dogan B; Erol I; Kayık G; Aksoydan B
    Curr Opin Struct Biol; 2019 Apr; 55():93-103. PubMed ID: 31082696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dynamic Process of Drug-GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics.
    Schneider S; Provasi D; Filizola M
    Methods Mol Biol; 2015; 1335():277-94. PubMed ID: 26260607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble Docking in Drug Discovery: How Many Protein Configurations from Molecular Dynamics Simulations are Needed To Reproduce Known Ligand Binding?
    Evangelista Falcon W; Ellingson SR; Smith JC; Baudry J
    J Phys Chem B; 2019 Jun; 123(25):5189-5195. PubMed ID: 30695645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
    Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peeking at G-protein-coupled receptors through the molecular dynamics keyhole.
    Deganutti G; Moro S; Reynolds CA
    Future Med Chem; 2019 Mar; 11(6):599-615. PubMed ID: 30888844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Conformational State Transitions of Class B GPCRs Using Molecular Dynamics.
    Liao C; May V; Li J
    Methods Mol Biol; 2019; 1947():3-19. PubMed ID: 30969408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova.
    Ciancetta A; Cuzzolin A; Deganutti G; Sturlese M; Salmaso V; Cristiani A; Sabbadin D; Moro S
    Mol Inform; 2016 Sep; 35(8-9):440-8. PubMed ID: 27546048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling study on the dynamical structural features of human smoothened receptor and binding mechanism of antagonist LY2940680 by metadynamics simulation and free energy calculation.
    Bai Q; Shen Y; Jin N; Liu H; Yao X
    Biochim Biophys Acta; 2014 Jul; 1840(7):2128-38. PubMed ID: 24637074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
    An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
    ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Receptor-ligand docking simulation for membrane proteins].
    Hirokawa T
    Yakugaku Zasshi; 2007 Jan; 127(1):123-31. PubMed ID: 17202792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Ligand Binding Selectivity in a Prototypical GPCR Family.
    Mattedi G; Deflorian F; Mason JS; de Graaf C; Gervasio FL
    J Chem Inf Model; 2019 Jun; 59(6):2830-2836. PubMed ID: 31125224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor.
    Kappel K; Miao Y; McCammon JA
    Q Rev Biophys; 2015 Nov; 48(4):479-87. PubMed ID: 26537408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.